1. Covid-19: Indian health officials defend approval of vaccine
2. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
3. Bhuyan A. How Covaxin trial participants in Bhopal were misled. The Wire. 14 Jan 2021. https://science.thewire.in/health/peoples-hospital-bhopal-covaxin-clinical-trials-exploitation-ethics-ground-report.
4. Nichenametla P. Bhopal volunteer’s death unrelated to Covaxin, says Bharat Biotech. Deccan Herald. 10 Jan 2021. https://www.deccanherald.com/national/bhopal-volunteers-death-unrelated-to-covaxin-says-bharat-biotech-937199.html.
5. Omjasvin MD. Alleging side-effects from Covishield vaccine trials, Chennai-based volunteer seeks Rs 5 crore compensation. New Indian Express. 29 Nov 2020. https://www.newindianexpress.com/cities/chennai/2020/nov/29/alleging-side-effects-from-covishield-vaccine-trials-chennai-based-volunteer-seeks-rs-5-crore-compen-2229651.html.